Kura Oncology

KURA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$17.3M

Previous year: $53.9M

-67.8%

EPS

-$0.92

Previous year: -$0.22

+318.2%

R&D Expenses

$64.4M

Previous year: $52.3M

+23.2%

SG&A Expenses

$39.1M

Previous year: $24.1M

+62.6%

Total Operating Expenses

$104M

Previous year: $76.3M

Loading...

Kura Oncology

Unlock previous datapoints

Upgrade

Kura Oncology

Unlock previous datapoints

Upgrade

Kura Oncology Revenue by Segment

Revenue by Segment

Net Product Revenue

CapyFin.com

Collaboration Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$761M

P/E Ratio

-3.55

Sector

N/A

Industry

N/A

52-Week High

$12.1

52-Week Low

$5.52

R&D Expenses

$64.4M

SG&A Expenses

$39.1M

Total Operating Expenses

$104M

Share-based Compensation

$11.3M

Other Income, Net

$5.34M

Products

Get in Touch

Resources

Kura Oncology

Kura Oncology

Kura Oncology

Kura Oncology Revenue by Segment

Revenue by Segment

Net Product Revenue

Collaboration Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics